← All trials
NCT02869035
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2016
- Primary completion
- Jul 1, 2019
- Completion date
- Jul 1, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 100
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- University of CopenhagenLead sponsor
- University of CopenhagenReponsible party - principal investigator
- Central Visitation, Region HovedstadenCollaborator
- University of CopenhagenCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.